Investing Profile

Andrea van Elsas

InvestorVC

Partner at Third Rock Ventures

thirdrockventures.com/people/...Oakland, California

Your Intro Paths to Andrea van Elsas

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Andrea van is a member of

UC Berkeley Network

18 CONNECTIONS

Third Rock Ventures Network

13 CONNECTIONS

Third Rock Ventures Network

13 CONNECTIONS

Find Andrea van Elsas on

Current Investing Position

Third Rock Ventures Partner

Investment Range

$100K - $5.0M

Sweet Spot

$100K

Current Fund Size

$770M

Andrea van Elsas is on these Sector & Stage Rankings

BioTech (Series B)Pharmaceuticals (Seed)BioTech (Seed)Pharmaceuticals (Series B)Pharmaceuticals (Series A)BioTech (Series A)San Francisco Bay Area Boston / New England

Andrea van Elsas's Experience

Partner Third Rock Ventures2022 - Present

Chief Scientific Officer Clasp Therapeutics2021 - Present

Chief Scientific Officer Abata Therapeutics2021 - Present

SAB member InteRNA Technologies BV2019 - Present

Board Member DCprime bv2019 - Present

Scientific Advisory Board Chair Lava Therapeutics B.V.2018 - Present

Owner IREYA Consulting BV2011 - Present

Venture Partner Third Rock Ventures2020 - 2022

VP Research AM-Pharma2011 - 2022

Board Member Lava Therapeutics B.V.2018 - 2020

Operational Partner Gilde Healthcare2017 - 2020

CSO Aduro Biotech2017 - 2020

CSO & Director Aduro Biotech Europe2015 - 2017

Chief Scientific Officer BioNovion2012 - 2017

Senior Research Fellow Merck Sharp & Dohme2009 - 2011

Director Tumor Immunology Schering-Plough Research Institute2007 - 2009

Director Tumor Immunology Organon2007 - 2007

Section Head Organon Pharmaceuticals2004 - 2006

(Senior) Scientist to Fellow Organon1999 - 2004

Research Fellow KWF Kankerbestrijding1997 - 1999

postdoctoral fellow UC Berkeley1997 - 1998

graduate student Leiden University Medical Center1990 - 1996

Investors who invest with Andrea van Elsas

Founders who looked at Andrea van Elsas' profile also looked at these Scouts & Angels